Jean Jacques Bienaime - Mar 10, 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Chief Executive Officer, Director
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Mar 10, 2022
Transactions value $
-$1,206,900
Form type
4
Date filed
3/14/2022, 08:44 PM
Previous filing
Mar 10, 2022
Next filing
Mar 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Options Exercise $562K +15K +4.43% $37.46 354K Mar 10, 2022 Direct F1
transaction BMRN Common Stock Sale -$1.16M -15K -4.24% $77.57 339K Mar 10, 2022 Direct F1
transaction BMRN Common Stock Options Exercise $562K +15K +4.43% $37.46 354K Mar 11, 2022 Direct F1
transaction BMRN Common Stock Sale -$1.17M -15K -4.24% $77.81 339K Mar 11, 2022 Direct F1
holding BMRN Common Stock 248K Mar 10, 2022 Shares held by Jean-Jacques Bienaime Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to buy Common Stock) Options Exercise $0 -15K -13.04% $0.00 100K Mar 10, 2022 Common Stock 15K $37.46 Direct F1, F2
transaction BMRN Stock Option (Right to buy Common Stock) Options Exercise $0 -15K -15% $0.00 85K Mar 11, 2022 Common Stock 15K $37.46 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Trade made pursuant to a 10b5-1 plan executed on December 9, 2021.
F2 Reflects the number of options outstanding after the transactions from this specific stock option grant.